Groupe Berkem announced the launch of Biombalance, its new range of premium active ingredients for the Nutraceuticals market. Based on Groupe Berkem's deep expertise in plant extraction and the development of active ingredients, the Biombalance range of premium ingredients meets the demand for food supplements targeting intestinal microbiota balance, a health issue affecting millions of people worldwide. Thanks to its in-depth knowledge and expertise of plants and their active molecules, Groupe Berkem has selected ingredients targeting microbiota balance, restoring the intestinal barrier, reducing oxidative stress and restoring immune tolerance.

The product of this new range, Symgrape, is a premium active ingredient derived from the extraction of polyphenols from grape seeds, one of the Company's long-standing activities, themselves rigorously selected, sustainably sourced and endowed with significant scientifically proven benefits for intestinal health. With this new range, Groupe BerkeM strengthens its position in the fast-expanding Nutraceuticals market, and more specifically in the food supplements segment for intestinal health, estimated at $38.8 billion in 20212 and expected to grow by almost 9% a year between now and 20313. This product launch also follows on from the acquisition of i. Bioceuticals in February 2023, which enabled Groupe Berkem to enter North America, the world's leading Nutraceuticals market4, where Groupe Berkem had already been distributing its natural active ingredients for several decades.

Alongside Symgrape, the Biombalance?? range includes three additional premium ingredients with recognized virtually for the health of the human microbiota: Symint??, Mallowsym?? and Symthym??.

SupplySideWest show Groupe Berkem will present its new Nutraceuticals range of food supplements on October 25 & 26, 2023 at SupplySideWest show in Las Vegas, booth #6865.